BOSTON–(BUSINESS WIRE)–MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver transformative therapies to patients, today announced the promotion of Rami Rahal, Ph.D., to Partner. “We are proud to announce Rami’s well-deserved promotion in recognition of the tremendous value he has brought to the public investing team at MPM BioImpact,” said Christiana Bardon, M.D., Managing Partner of MPM BioImpact. “Our goal is to invest in companies